TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ARWR

Arrowhead Pharmaceuticals Inc

Healthcare · Biotechnology

64.20$ -0.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Arrowhead Pharmaceuticals Inc (ARWR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,112 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARWR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
128 144 127 115 104 88 127 113 112 341 334 337 350 588 561 556 523 499 757 735 710 639 704 752 692 891 891 796 766 626 955 884 1,140 1,014 1,573 1,381 1,385 1,604 2,268 2,112
91 106 90 78 68 53 93 62 79 249 235 245 265 508 314 315 322 324 587 526 385 338 418 432 376 502 575 470 420 238 542 450 695 571 1,135 947 951 1,174 1,840 1,671
85 102 62 38 25 12 70 28 30 190 162 188 222 461 257 219 144 140 372 326 184 92 86 139 108 202 135 105 111 58 128 69 103 54 186 130 227 202 189 55
85 102 87 75 66 51 92 60 77 244 218 237 259 502 308 287 315 305 577 516 368 330 402 416 376 502 481 452 404 220 523 437 681 553 1,097 900 919 917 1,784 1,602
0.1 0.1 0.6 0.9 0.1 0.1 0.0 0.0 0.3 3.2 13 2.0 0.7 1.3 1.3 22 0.8 9.0 1.0 0.7 10 0.2 1.3 0.2 1.4 40 69 1.2 0.0 – – – 0.0 2.5 2.4 9.7 6.8 219 16 8.6
1.3 0.6 0.7 0.9 0.9 0.7 0.7 1.1 1.3 1.6 1.8 4.1 3.3 2.7 3.1 4.1 4.3 7.1 6.6 7.3 4.4 5.2 6.6 6.8 -22 -65 9.9 10 – – – – – – – – – – – –
15 16 16 16 16 15 15 14 14 14 13 17 23 26 29 30 31 34 39 66 49 52 55 72 110 147 185 231 336 – – – – – – – – – – –
22 -21,718 21 -20,869 20 -20,019 20 -19,170 19 -18,321 18 17 17 -16,622 16 -15,772 15 15 – – – – – – – – – – – – – – – – – – – – – –
22 21,740 21 20,890 20 20,039 20 19,189 19 18,339 18 17 17 16,638 16 15,788 15 15 15 14 14 13 13 12 12 12 11 11 10 9.8 9.4 9.0 8.6 8.1 7.7 7.3 6.9 6.4 6.0 5.6
33 47 34 26 23 18 13 11 16 169 133 111 106 88 68 63 61 45 311 298 301 266 251 278 274 495 426 414 478 453 460 545 949 958 889 861 882 1,041 1,669 1,646
26 37 28 20 19 14 9.1 7.1 12 135 102 87 97 74 53 43 41 25 167 195 147 137 139 128 139 122 87 70 105 64 65 97 103 94 221 195 195 347 295 283
0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 – – 12 0.5 0.7 1.0 1.1 1.2 1.3 1.3 2.3 2.8 2.9 2.9 2.8 2.7 2.7 2.8 11 3.4 5.3 6.1 6.3 8.2 72 47 47 48 48 40
12 3.7 2.6 3.2 4.1 5.7 1.8 2.2 2.8 3.9 4.1 4.6 7.6 12 13 4.1 6.8 4.8 5.3 10 9.5 4.1 11 5.9 2.9 0.8 9.6 7.9 36 4.5 8.5 27 11 14 10.0 33 18 33 31 28
2.5 2.5 2.4 2.4 2.3 2.3 2.2 2.2 2.1 – – – – – – – – – – – – – – – – – – – – – – – 393 408 209 200 215 163 842 824
96 98 94 90 81 71 114 102 96 172 201 226 245 500 494 493 462 454 446 437 409 373 452 454 399 377 447 365 271 160 484 331 185 53 683 522 466 568 614 466
-398 -411 -417 -422 -433 -446 -461 -477 -487 -475 -451 -431 -419 -422 -442 -455 -504 -525 -551 -581 -645 -708 -663 -735 -821 -862 -813 -916 -1,026 -1,159 -1,284 -1,455 -1,626 -1,799 -1,428 -1,603 -1,627 -1,596 -1,729 -1,923
71 71 75 75 75 75 84 88 96 96 98 99 97 97 102 102 103 103 104 104 105 105 108 106 106 106 108 107 107 107 123 124 122 125 134 139 136 141 142 143

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?